Caption Management, LLC Altimmune, Inc. Put Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	BUY	$4.19 - $16.83 $5.1 Million - $20.5 Million	1,216,700 New	1,216,700 $5.13 Million
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $1.56 Million - $3.27 Million	146,000 New	146,000 $1.86 Million
Q4 2021 Feb 11, 2022	BUY	$8.69 - $12.48 $178,145 - $255,840	20,500 Added 10.25%	220,500 $2.02 Million
Q3 2021 Nov 12, 2021	BUY	$8.43 - $16.81 $1.69 Million - $3.36 Million	200,000 New	200,000 $2.26 Million

186

39.4M

913K

743K

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $336M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.